We thank you for the kind contribution to the CKTTD database. Please feel free to submit new checkpoint entities (targets, modulators or miRNAs) in cancer immunotherapy to make the CKTTD a better resource. You can submit the entities in Word or Plain Text format.


Photo credited to: Eye of Science / Science Photo Library

The lung cells (brown), cancerous cells (purple), and mucus (grey) as shown by scanning electron microscope. Clinical trials of immune checkpoint inhibitors seem to improve survival rates in hard-to-treat cancers.